EUVIMEDEUVIMED entdecken
Open Access

Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature

Kristy J Gotink, Henk J Broxterman, Richard J Honeywell, Henk Dekker, Richard R de Haas, Kiersten M Miles, Remi Adelaiye, Arjan W Griffioen, Godefridus J Peters, Roberto Pili, Henk M W Verheul

Oncoscience · 2014

DOI: 10.18632/oncoscience.106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncoscience, 2014. Verfasst von Kristy J Gotink und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands ; Department of Medicine, Genitourinary Section, Roswell Par…. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Sunitinibangiogenesishost-factorslysosomesresistance

Autor:innen und Institutionen

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands ; Department of Medicine, Genitourinary Section, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Department of Medicine, Genitourinary Section, Roswell Park Cancer Institute, Buffalo, NY, USA.

Zitieren

APA

Gotink, K. J., Broxterman, H. J., Honeywell, R. J., Dekker, H., de Haas, R. R., Miles, K. M., Adelaiye, R., Griffioen, A. W., Peters, G. J., Pili, R., & Verheul, H. M. (2014). Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature. Oncoscience. https://doi.org/10.18632/oncoscience.106

Vancouver

Gotink KJ, Broxterman HJ, Honeywell RJ, Dekker H, de Haas RR, Miles KM, et al. Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature. Oncoscience. 2014. doi:10.18632/oncoscience.106

BibTeX
@article{Gotink2014,
  author = {Gotink, Kristy J and Broxterman, Henk J and Honeywell, Richard J and Dekker, Henk and de Haas, Richard R and Miles, Kiersten M and Adelaiye, Remi and Griffioen, Arjan W and Peters, Godefridus J and Pili, Roberto and Verheul, Henk M W},
  title = {Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature},
  journal = {Oncoscience},
  year = {2014},
  doi = {10.18632/oncoscience.106}
}
Kostenlos starten →